Dolat Capital's research report on PI Industries
Focusing on leveraging existing collaborations with the innovator companies in both the businesses – domestic agri-inputs and CSM exports. In domestic agri-inputs by entering into exclusive marketing rights of novel molecules in India with the innovators and in the CSM exports by deepening R&D capabilities, consequently resulting in commercialization of new molecules. To drive future growth company also hinted at venturing in business opportunities beyond agchem.
Outlook
Company expect to deliver growth in the coming years as new commercialised molecules scale up, capacity expansion at Jambusar, acceleration in pick-up of export shipments and company’s continued investment in R&D. The company also believes looking at non agchem domain as well, upon fruition can provide sustainable growth for the company.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
Read More
